Invesaro

Stocks Health care SLBT

NASDAQ · Health care

SL Science Holding Ltd (SLBT)

We have not processed filings for SL Science Holding Ltd yet. This page fills in on its own once we have read them.

Free, no password. An email when SLBT files with the SEC.

Price
$0.99
+1.18% on the day · November 10, 2026
52-week range $0.74 to $14.50
Market cap
$555.1M

Key facts about SL Science Holding Ltd

Net worth
SL Science Holding Ltd has a market value (market cap) of $555.1M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on June 18, 2026 and covers the period to June 12, 2026. Open on SEC EDGAR

What SL Science Holding Ltd does

SL Science Holding Ltd is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker SLBT.

Earnings: every quarter and the next report date

Latest SEC filings

What SL Science Holding Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 3, 2026
  2. October 26, 2026
  3. October 9, 2026
  4. October 1, 2026
  5. September 24, 2026
  6. September 1, 2026
  7. August 27, 2026
  8. July 31, 2026
  9. July 10, 2026
  10. June 18, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on November 6, 2026. Insider transactions on SEC

Insider trades

What the people running SL Science Holding Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought shares on the open market in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
Net bought
4,545,306
$0
DateInsiderWhatSharesPriceValueFiling
September 29, 2026 Wang Ching-DongChief Executive Officer, Director, 10% owner Boughtindirect 4,545,306 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns SLBT

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

We have not read this company's Schedule 13D and 13G filings yet.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 333,832,129 shares in total, about $330.5M at the last price.

HolderSharesAs of
Wang Ching-DongChief Executive Officer, Director, 10% owner 333,832,129333,832,129 held indirectly September 29, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SLBT

What does SL Science Holding Ltd do?

SL Science Holding Ltd is a company in the Health care sector, listed on NASDAQ as SLBT. Its shares trade on NASDAQ under the ticker SLBT.

What is SL Science Holding Ltd's net worth?

SL Science Holding Ltd has a market value (market cap) of $555.1M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.

When did SL Science Holding Ltd last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on June 18, 2026. It covers the period to June 12, 2026. Its newest filing of any kind is the new insider holdings from November 6, 2026.

Similar companies

Compare SLBT with

Compare SLBT with any company

Follow SLBT

Get an email when SL Science Holding Ltd files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when SLBT files with the SEC.

Where the numbers come from

Financial figures are the values SL Science Holding Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.